Androgen supplementation and risk for prostate cancer

A new paper from a research team in Seattle probably has limited relevance to our understanding of the real risks associated with androgen supplementation and subequent diagnosis of prostate cancer (or other prostate disorders) — even though it was a randomized, double-blind clinical trial. … READ MORE …